NCT07119073View on ClinicalTrials.gov

In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

December 21, 2024

Study Completion Date

December 27, 2024

Conditions
Healthy Volunteers in Fed and Fasted State
Interventions
DRUG

Dexmethylphenidate

Subjects will be randomized to one of two sequences. Subjects will be dosed with 50 mg dose of Cox-1301 during each sequence. Subjects will serve as their own control.

Trial Locations (1)

66212

Dr. Vince Clinical Research, Overland Park

Sponsors
All Listed Sponsors
lead

Cingulate Therapeutics

INDUSTRY

NCT07119073 - In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted) | Biotech Hunter | Biotech Hunter